Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters

Complementary Medicines
Country/Region as subject
Publication year range
1.
BMC Med Res Methodol ; 22(1): 46, 2022 02 16.
Article in English | MEDLINE | ID: mdl-35172746

ABSTRACT

BACKGROUND: Two-stage least square [2SLS] and two-stage residual inclusion [2SRI] are popularly used instrumental variable (IV) methods to address medication nonadherence in pragmatic trials with point treatment settings. These methods require assumptions, e.g., exclusion restriction, although they are known to handle unmeasured confounding. The newer IV-method, nonparametric causal bound [NPCB], showed promise in reducing uncertainty compared to usual IV-methods. The inverse probability-weighted per-protocol [IP-weighted PP] method is useful in the same setting but requires different assumptions, e.g., no unmeasured confounding. Although all of these methods are aimed to address the same nonadherence problem, comprehensive simulations to compare performances of them are absent in the literature. METHODS: We performed extensive simulations to compare the performances of the above methods in addressing nonadherence when: (1) exclusion restriction satisfied and no unmeasured confounding, (2) exclusion restriction is met but unmeasured confounding present, and (3) exclusion restriction is violated. Our simulations varied parameters such as, levels of adherence rates, unmeasured confounding, and exclusion restriction violations. Risk differences were estimated, and we compared performances in terms of bias, standard error (SE), mean squared error (MSE), and 95% confidence interval coverage probability. RESULTS: For setting (1), 2SLS and 2SRI have small bias and nominal coverage. IP-weighted PP outperforms these IV-methods in terms of smaller MSE but produces high MSE when nonadherence is very high. For setting (2), IP-weighted-PP generally performs poorly compared to 2SLS and 2SRI in term of bias, and both-stages adjusted IV-methods improve precision than naive IV-methods. For setting (3), IV-methods perform worst in all scenarios, and IP-weighted-PP produces unbiased estimates and small MSE when confounders are adjusted. NPCB produces larger uncertainty bound width in almost all scenarios. We also analyze a two-arm trial to estimate vitamin-A supplementation effect on childhood mortality after addressing nonadherence. CONCLUSIONS: Understanding finite sample characteristics of these methods will guide future researchers in determining suitable analysis strategies. Since assumptions are different and often untestable for IP-weighted PP and IV methods, we suggest analyzing data using both IP-weighted PP and IV approaches in search of a robust conclusion.


Subject(s)
Pragmatic Clinical Trials as Topic , Treatment Adherence and Compliance , Bias , Causality , Child , Computer Simulation , Confounding Factors, Epidemiologic , Humans , Least-Squares Analysis
2.
Biom J ; 64(2): 225-234, 2022 02.
Article in English | MEDLINE | ID: mdl-33377537

ABSTRACT

In their paper, Liu et al. (2020) pointed out illogical discrepancies between subgroup and overall causal effects for some efficacy measures, in particular the odds and hazard ratios. As the authors show, the culprit is subgroups having prognostic effects within treatment arms. In response to their provocative findings, we found that the odds and hazard ratios are logic respecting when the subgroups are purely predictive, that is, the distribution of the potential outcome for the control treatment is homogeneous across subgroups. We also found that when we redefined the odds and hazards ratio causal estimands in terms of the joint distribution of the potential outcomes, the discrepancies are resolved under specific models in which the potential outcomes are conditionally independent. In response to other discussion points in the paper, we also provide remarks on association versus causation, confounding, statistical computing software, and dichotomania.


Subject(s)
Logic , Software , Plant Extracts , Proportional Hazards Models , Randomized Controlled Trials as Topic
3.
Clin Oral Investig ; 26(3): 2421-2427, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34618231

ABSTRACT

BACKGROUND: Positive and negative influences on oral health are attributed to coffee consumption. The aim of the current study is to evaluate the association between coffee consumption and periodontitis in the general population of Hamburg. METHODS: A total of 6,209 participants from the Hamburg City Health Study were included in this cross-sectional study. Information on coffee consumption was collected using a food frequency questionnaire. Periodontal examination included assessment of dental care ability via Plaque Index, measurement of pocket depth, gingival recession, and bleeding on probing. Classification was based on the criteria of Eke and Page. Ordinal logistic regression models were performed unadjusted and adjusted for confounding variables. RESULTS: Periodontal cohort consists of 6,209 participants, presenting either none/mild (n = 1,453, 39.6% men, 2.4% strong coffee drinkers), moderate (n = 3,580, 49.3% men, 3.3% strong coffee drinkers), or severe (n = 1,176, 60.9% men, 5.0% strong coffee drinkers) periodontitis. There was a significant association between strong coffee consumption (≥ 7or more cups/day) and periodontitis (OR: 1.51; CI: 1.07, 2.12; p > 0.001), compared with low coffee consumption. Conversely, moderate coffee consumption was not associated with periodontitis, compared with low coffee consumption. CONCLUSION: and clinical relevance. In this cross-sectional study of a northern German population, strong coffee consumption was significantly associated with periodontitis. Influence of changes in coffee consumption on periodontal disease etiology/progression should be investigated in future prospective study designs, in order to identify strong coffee consumption as a potential risk factor of periodontitis.


Subject(s)
Periodontal Diseases , Periodontitis , Coffee/adverse effects , Cross-Sectional Studies , Dental Plaque Index , Female , Humans , Male , Periodontal Diseases/epidemiology , Periodontitis/epidemiology
4.
Handb Clin Neurol ; 179: 141-156, 2021.
Article in English | MEDLINE | ID: mdl-34225959

ABSTRACT

The quality of postmortem hypothalamus research depends strongly on a thorough clinical investigation and documentation of the patient's disorder and therapies. In addition, a systematic and professional neuropathological investigation of the entire brain of both the cases and the controls is absolutely crucial. In the experience of the Netherlands Brain Bank (NBB), about 20% of the clinical neurological diagnoses, despite being made in first rate clinics, have to be revised or require extra diagnoses after a complete and thorough neuropathologic review by the NBB. The neuropathology examination may reveal for instance that the elderly "controls" already have preclinical neurodegenerative alterations. In postmortem studies, the patient and control groups must be matched for as many as possible of the known confounding factors. This is necessary to make the groups as similar as possible, except for the topic being investigated. Confounding factors are present (i) before, (ii) during, and (iii) after death. They are, respectively: (i) genetic background, systemic diseases, duration and gravity of illness, medicines and addictive compounds used, age, sex, gender identity, sexual orientation, clock- and seasonal time of death, and lateralization; (ii) agonal state, stress of dying; and (iii) postmortem delay, freezing procedures, fixation, and storage time. Agonal state is generally estimated by measuring the pH of the brain. However, there are disorders in which pH is lower as a part of the disease process. Because of the large number of potentially confounding factors that differ according to, for instance, brain area and disease, a brain bank should have a large number of controls at its disposal for appropriate matching. If matching fails for some confounders, the influence of the confounders may be determined by statistical methods, such as analysis of variance or the regression models.


Subject(s)
Gender Identity , Postmortem Changes , Aged , Brain , Female , Humans , Hypothalamus , Male , Netherlands , Neuropathology
5.
Stat Methods Med Res ; 30(8): 1782-1799, 2021 08.
Article in English | MEDLINE | ID: mdl-34187236

ABSTRACT

Modern causal mediation theory has formalized several types of indirect and direct effects of treatment on outcomes regarding specific mediator variables. We reviewed and unified distinct approaches to estimate the "interventional" direct and indirect effects for multiple mediators and time-varying variables. This study was motivated by a clinical trial of elderly type-2 diabetic patients in which atorvastatin was widely prescribed to control patients' cholesterol levels to reduce diabetic complications, including cardiovascular disease. Among atorvastatin's preventive side-effects (pleiotropic effects), we focus on its anti-inflammatory action as measured by white blood cell counts. Hence, we estimate atorvastatin's interventional indirect effects through cholesterol lowering and through anti-inflammatory action, and interventional direct effect bypassing these two actions. In our analysis, total effect (six-year cardiovascular disease risk difference) estimated by standard plug-in g-formula of -3.65% (95% confidence interval: -10.29%, 4.38%) is decomposed into indirect effect via low-density lipoprotein cholesterol (-0.90% [-1.91%, -0.07%]), via white blood cell counts (-0.03% [-0.22%, 0.11%]), and direct effect (-2.84% [-9.71%, 5.41%]) by the proposed parametric mediational g-formula. The SAS program and its evaluation via simulated datasets are provided in the Supplemental materials.


Subject(s)
Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Aged , Anti-Inflammatory Agents , Atorvastatin , Cardiovascular Diseases/drug therapy , Cardiovascular Diseases/prevention & control , Cholesterol , Diabetes Mellitus, Type 2/drug therapy , Humans
6.
Endocr Connect ; 9(9): R195-R206, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33052876

ABSTRACT

Our knowledge of vitamin D has come a long way since the 100 years it took for doctors to accept, between 1860 and 1890, that both sunlight and cod liver oil (a well-known folk remedy) cured and prevented rickets. Vitamins D2/D3 were discovered exactly a hundred years ago, and over the last 50 years vitamin D has been found to have many effects on virtually all human tissues and not just on bone health, while mechanisms affecting the actions of vitamin D at the cellular level are increasingly understood, but deficiency persists globally. Observational studies in humans have shown that better provision of vitamin D is strongly associated, dose-wise, with reductions in current and future health risks in line with the known actions of vitamin D. Randomised controlled trials, commonly accepted as providing a 'gold standard' for assessing the efficacy of new forms of treatment, have frequently failed to provide supportive evidence for the expected health benefits of supplementation. Such RCTs, however, have used designs evolved for testing drugs while vitamin D is a nutrient; the appreciation of this difference is critical to identifying health benefits from existing RCT data and for improving future RCT design. This report aims, therefore, to provide a brief overview of the evidence for a range of non-bony health benefits of vitamin D repletion; to discuss specific aspects of vitamin D biology that can confound RCT design and how to allow for them.

7.
Clin Trials ; 17(4): 351-359, 2020 08.
Article in English | MEDLINE | ID: mdl-32522024

ABSTRACT

Electronic health record data can be used in multiple ways to facilitate real-world pragmatic studies. Electronic health record data can provide detailed information about utilization of treatment options to help identify appropriate comparison groups, access historical clinical characteristics of participants, and facilitate measuring longitudinal outcomes for the treatments being studied. An additional novel use of electronic health record data is to assess and understand referral pathways and other business practices that encourage or discourage patients from using different types of care. We describe an ongoing study utilizing access to real-time electronic health record data about changing patterns of complementary and integrative health services to demonstrate how electronic health record data can provide the foundation for a pragmatic study when randomization is not feasible. Conducting explanatory trials of the value of emerging therapies within a healthcare system poses ethical and pragmatic challenges, such as withholding access to specific services that are becoming widely available to patients. We describe how prospective examination of real-time electronic health record data can be used to construct and understand business practices as potential surrogates for direct randomization through an instrumental variables analytic approach. In this context, an example of a business practice is the internal hiring of acupuncturists who also provide yoga or Tai Chi classes and can offer these classes without additional cost compared to community acupuncturists. Here, the business practice of hiring internal acupuncturists is likely to encourage much higher rates of combined complementary and integrative health use compared to community referrals. We highlight the tradeoff in efficiency of this pragmatic approach and describe use of simulations to estimate the potential sample sizes needed for a variety of instrument strengths. While real-time monitoring of business practices from electronic health records provides insights into the validity of key independence assumptions associated with the instrumental variable approaches, we note that there may be some residual confounding by indication or selection bias and describe how alternative sources of electronic health record data can be used to assess the robustness of instrumental variable assumptions to address these challenges. Finally, we also highlight that while some clinical outcomes can be obtained directly from the electronic health record, such as longitudinal opioid utilization and pain intensity levels for the study of the value of complementary and integrative health, it is often critical to supplement clinical electronic health record-based measures with patient-reported outcomes. The experience of this example in evaluating complementary and integrative health demonstrates the use of electronic health record data in several novel ways that may be of use for designing future pragmatic trials.


Subject(s)
Complementary Therapies/methods , Electronic Health Records , Pain Management , Patient Reported Outcome Measures , Pragmatic Clinical Trials as Topic/methods , Computer Simulation , Humans , Integrative Medicine , Pain , Pain Measurement , Prospective Studies , Referral and Consultation , Research Design , Sample Size , Self Care
8.
J Med Life ; 13(1): 37-44, 2020.
Article in English | MEDLINE | ID: mdl-32341699

ABSTRACT

This study empirically illustrates the mechanism by which epidemiological effect measures and statistical evidence can be misleading in the presence of Simpson's paradox and identify possible alternative methods of analysis to manage the paradox. Three scenarios of observational study designs, including cross-sectional, cohort, and case-control approaches, are simulated. In each scenario, data are generated, and various methods of epidemiological and statistical analyses are undertaken to obtain empirical results that illustrate Simpson's paradox and mislead conclusions. Rational methods of analysis are also performed to illustrate how to avoid pitfalls and obtain valid results. In the presence of Simpson's paradox, results from analyses in overall data contradict the findings from all subgroups of the same data. This paradox occurs when distributions of confounding characteristics are unequal in the groups being compared. Data analysis methods which do not take confounding factor into account, including epidemiological 2×2 table analysis, independent samples t-test, Wilcoxon rank-sum test, chi-square test, and univariable regression analysis, cannot manage the problem of Simpson's paradox and mislead research conclusions. Mantel-Haenszel procedure and multivariable regression methods are examples of rational analysis methods leading to valid results. Therefore, Simpson's paradox arises as a consequence of extreme unequal distributions of a specific inherent characteristic in groups being compared. Analytical methods which take control of confounding effect must be applied to manage the paradox and obtain valid research evidence regarding the causal association.


Subject(s)
Epidemiologic Studies , Observational Studies as Topic , Research Design , Statistics as Topic , Case-Control Studies , Coffee , Cohort Studies , Cross-Sectional Studies , Dentists , Female , Humans , Influenza Vaccines/immunology , Male , Multivariate Analysis , Regression Analysis
9.
Am J Epidemiol ; 189(3): 224-234, 2020 03 02.
Article in English | MEDLINE | ID: mdl-31673702

ABSTRACT

Studies have shown that accounting for time-varying confounding through time-dependent Cox proportional hazards models may provide biased estimates of the causal effect of treatment when the confounder is also a mediator. We explore 2 alternative approaches to addressing this problem while examining the association between vitamin D supplementation initiated after breast cancer diagnosis and all-cause mortality. Women aged 50-80 years were identified in the National Cancer Registry Ireland (n = 5,417) between 2001 and 2011. Vitamin D use was identified from linked prescription data (n = 2,570). We sought to account for the time-varying nature of vitamin D use and time-varying confounding by bisphosphonate use using 1) marginal structural models (MSMs) and 2) G-estimation of structural nested accelerated failure-time models (SNAFTMs). Using standard adjusted Cox proportional hazards models, we found a reduction in all-cause mortality in de novo vitamin D users compared with nonusers (hazard ratio (HR) = 0.84, 95% confidence interval (CI): 0.73, 0.99). Additional adjustment for vitamin D and bisphosphonate use in the previous month reduced the hazard ratio (HR = 0.45, 95% CI: 0.33, 0.63). Results derived from MSMs (HR = 0.44, 95% CI: 0.32, 0.61) and SNAFTMs (HR = 0.45, 95% CI: 0.34, 0.52) were similar. Utilizing MSMs and SNAFTMs to account for time-varying bisphosphonate use did not alter conclusions in this example.


Subject(s)
Bone Density Conservation Agents/therapeutic use , Breast Neoplasms/drug therapy , Models, Statistical , Registries , Vitamin D/therapeutic use , Aged , Breast Neoplasms/mortality , Confounding Factors, Epidemiologic , Diphosphonates/administration & dosage , Female , Humans , Ireland/epidemiology , Middle Aged , Time Factors
10.
IEEE Trans Hum Mach Syst ; 50(4): 287-297, 2020 Aug.
Article in English | MEDLINE | ID: mdl-33777542

ABSTRACT

Computer cursor control using electroencephalogram (EEG) signals is a common and well-studied brain-computer interface (BCI). The emphasis of the literature has been primarily on evaluation of the objective measures of assistive BCIs such as accuracy of the neural decoder whereas the subjective measures such as user's satisfaction play an essential role for the overall success of a BCI. As far as we know, the BCI literature lacks a comprehensive evaluation of the usability of the mind-controlled computer cursor in terms of decoder efficiency (accuracy), user experience, and relevant confounding variables concerning the platform for the public use. To fill this gap, we conducted a two-dimensional EEG-based cursor control experiment among 28 healthy participants. The computer cursor velocity was controlled by the imagery of hand movement using a paradigm presented in the literature named imagined body kinematics (IBK) with a low-cost wireless EEG headset. We evaluated the usability of the platform for different objective and subjective measures while we investigated the extent to which the training phase may influence the ultimate BCI outcome. We conducted pre- and post- BCI experiment interview questionnaires to evaluate the usability. Analyzing the questionnaires and the testing phase outcome shows a positive correlation between the individuals' ability of visualization and their level of mental controllability of the cursor. Despite individual differences, analyzing training data shows the significance of electrooculogram (EOG) on the predictability of the linear model. The results of this work may provide useful insights towards designing a personalized user-centered assistive BCI.

11.
Int J Toxicol ; 38(3): 228-234, 2019.
Article in English | MEDLINE | ID: mdl-30975012

ABSTRACT

A number of issues may arise during the conduct of a study which can complicate interpretation of in vitro and in vivo datasets. Speakers discussed the implications of differing interpretations and how to avoid complicating factors during study planning and execution. Consideration needs to be given to study design factors including defining objectives, consideration of expected pharmacological effects, dose selection and drug kinetics, species used, and vehicle selection. In addition, the effects of vivarium temperature effects on various endpoints, how to control variables affecting clinical pathology, and how early death animals, common background findings, and artifacts can affect histopathology interpretation all play into the final interpretation of study data.


Subject(s)
Drug Evaluation, Preclinical/methods , Research Design , Animal Experimentation , Animals
12.
Int J Food Sci Nutr ; 70(1): 88-97, 2019 Feb.
Article in English | MEDLINE | ID: mdl-29697292

ABSTRACT

Sugar sweetened beverages (SSB), artificially sweetened beverages (ASB), juice, coffee and tea has been associated with risk of metabolic disease. High consumption of these beverages may be associated with certain characteristics of the overall diet that would be important to take into account when analysing beverage-disease associations. Here, we investigate five beverages and their association with lifestyle and diet in 25,112 individuals from the Malmö Diet and Cancer Cohort. We observed that high consumption of SSB was associated with lower intakes of foods perceived as healthy. However, high consumption of both tea and juice was associated with higher intakes of foods perceived as healthy. Further, high consumption of ASB was associated with higher intakes of low-fat products. High consumption of coffee was associated with higher intakes of meat and high-fat margarine, and lower intake of breakfast cereals. We observe five beverages to associate with different lifestyle and dietary patterns.


Subject(s)
Beverages/adverse effects , Diet , Energy Intake , Feeding Behavior , Life Style , Adult , Aged , Coffee , Cohort Studies , Diet/statistics & numerical data , Diet, High-Fat , Female , Fruit and Vegetable Juices , Humans , Male , Middle Aged , Nutrition Surveys , Public Health , Surveys and Questionnaires , Sweden , Sweetening Agents/adverse effects , Tea
13.
Article in English | MEDLINE | ID: mdl-29779488

ABSTRACT

INTRODUCTION: Bisphenol A (BPA) is suspected to cause hormonal imbalance in humans. Dietary factors are known to bring changes in hormonal profile. In order to study chemico-biological interaction of iron deficiency on toxicity outcome of BPA exposure, we studied the modulatory effects of iron deficiency on the hormone levels in rats chronically-exposed to BPA. METHODS: Weanling rats maintained on normal and iron-deficient diets were exposed to low level of BPA at 0, 1, 5 and 10 ppm for six months through drinking water. The serum levels of thyroidstimulating hormone (TSH), testosterone, progesterone and estradiol were measured in the animals by enzyme-linked immunosorbent assay kit. Histopathology was performed to check the pathological changes in gonads. RESULTS: No significant change was observed in TSH, progesterone and estradiol levels at 1 and 5 ppm BPA. However, at 10 ppm BPA a significant increase in TSH level was observed in the animals maintained on an iron-deficient diet of either sex. BPA caused a significant change in testosterone level even at 5 and 10 ppm doses in animals of either sex. However, in male rats 1 ppm dose also showed a significant effect in the animals maintained on iron deficient diet. Changes in the histoarchitecture of the testes at high dose of BPA (10 ppm) were more remarkable in anemic rats. CONCLUSION: These results suggest that iron deficiency has no generalized effect on hormonal levels in BPA-treated animals and trends indicate a more remarkable effect in male animals at hormonal and tissue levels.


Subject(s)
Anemia, Iron-Deficiency/blood , Benzhydryl Compounds/toxicity , Endocrine Disruptors/toxicity , Hormones/blood , Phenols/toxicity , Testis/drug effects , Anemia, Iron-Deficiency/diagnosis , Anemia, Iron-Deficiency/pathology , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Estradiol/blood , Female , Male , Ovary/drug effects , Ovary/metabolism , Ovary/pathology , Progesterone/blood , Rats, Wistar , Sex Factors , Testis/metabolism , Testis/pathology , Testosterone/blood , Thyrotropin/blood , Time Factors , Weaning
14.
Anal Bioanal Chem ; 410(11): 2689-2699, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29476235

ABSTRACT

It is well recognized that physiological and environmental factors such as race, age, gender, and diurnal cycles often have a definite influence on metabolic results that statistically manifests as confounding variables. Currently, removal or controlling of confounding effects relies heavily on experimental design. There are no available data processing techniques focusing on the compensation of their effects. We therefore proposed a new method, Metabolic confounding effect elimination (MCEE), to remove the influence of specified confounding factors and make the data more accurate. The method consists of three steps: metabolites grouping, confounder-related metabolites selection, and metabolites modification. Its effectiveness and advantages were evaluated comprehensively by several simulated models and real datasets, and were compared with two typical methods, the principal component analysis (PCA)- and the direct orthogonal signal correction (DOSC)-based methods. MCEE is simple, effective, and safe, and is independent of sample number, association degree, and missing value. Hence, it may serve as a good complement to existing metabolomics data preprocessing methods and aid in better understanding the metabolic and biological status of interest. Graphical Abstract Algorithm flow and demo performance of MCEE.


Subject(s)
Metabolomics/methods , Algorithms , Arthritis/metabolism , Biomarkers/metabolism , Carcinoma, Hepatocellular/metabolism , Computer Simulation , Humans , Liver Neoplasms/metabolism , Models, Biological , Principal Component Analysis
15.
Psychiatry Res ; 256: 188-193, 2017 10.
Article in English | MEDLINE | ID: mdl-28645079

ABSTRACT

Desire thinking and mindfulness have been associated with craving. The aim of the present study was to validate the French version of the Desire Thinking Questionnaire (DTQ) and to investigate the relationship between mindfulness, desire thinking and craving among a sample of university students. Four hundred and ninety six university students completed the DTQ and measures of mindfulness, craving and alcohol use. Results from confirmatory factor analyses showed that the two-factor structure proposed in the original DTQ exhibited suitable goodness-of-fit statistics. The DTQ also demonstrated good internal reliability, temporal stability and predictive validity. A set of linear regressions revealed that desire thinking had a confounding effect in the relationship between mindfulness and craving. The confounding role of desire thinking in the relationship between mindfulness and craving suggests that interrupting desire thinking may be a viable clinical option aimed at reducing craving.


Subject(s)
Craving/physiology , Mindfulness , Adolescent , Adult , Alcohol Drinking/psychology , Cross-Cultural Comparison , Female , Humans , Male , Reproducibility of Results , Surveys and Questionnaires , Translations , Young Adult
16.
Int J Cancer ; 141(3): 480-487, 2017 08 01.
Article in English | MEDLINE | ID: mdl-28425616

ABSTRACT

Animal and human data suggest statins may be protective against developing multiple myeloma; however, findings may be biased by the interrelationship with lipid levels. We investigated the association between statin use and risk of multiple myeloma in a large US population, with an emphasis on accounting for this potential bias. We conducted a case-control study nested within 6 US integrated healthcare systems participating in the National Cancer Institute-funded Cancer Research Network. Adults aged ≥40 years who were diagnosed with multiple myeloma from 1998-2008 were identified through cancer registries (N = 2,532). For each case, five controls were matched on age, sex, health plan, and membership duration prior to diagnosis/index date. Statin prescriptions were ascertained from electronic pharmacy records. To address potential biases related to lipid levels and medication prescribing practices, multivariable marginal structural models were used to model statin use (≥6 cumulative months) and risk of multiple myeloma, with examination of multiple latency periods. Statin use 48-72 months prior to diagnosis/index date was associated with a suggestive 20-28% reduced risk of developing multiple myeloma, compared to non-users. Recent initiation of statins was not associated with myeloma risk (risk ratio range 0.90-0.99 with 0-36 months latency). Older patients had more consistent protective associations across all latency periods (risk ratio range 0.67-0.87). Our results suggest that the association between statin use and multiple myeloma risk may vary by exposure window and age. Future research is warranted to investigate the timing of statin use in relation to myeloma diagnosis.


Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Multiple Myeloma/chemically induced , Multiple Myeloma/epidemiology , Registries/statistics & numerical data , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prevalence , Prognosis , Risk Factors , United States/epidemiology
17.
Mov Disord ; 32(5): 739-749, 2017 05.
Article in English | MEDLINE | ID: mdl-28195358

ABSTRACT

BACKGROUND: There is mounting evidence for a connection between the gut and Parkinson's disease (PD). Dysbiosis of gut microbiota could explain several features of PD. OBJECTIVE: The objective of this study was to determine if PD involves dysbiosis of gut microbiome, disentangle effects of confounders, and identify candidate taxa and functional pathways to guide research. METHODS: A total of 197 PD cases and 130 controls were studied. Microbial composition was determined by 16S rRNA gene sequencing of DNA extracted from stool. Metadata were collected on 39 potential confounders including medications, diet, gastrointestinal symptoms, and demographics. Statistical analyses were conducted while controlling for potential confounders and correcting for multiple testing. We tested differences in the overall microbial composition, taxa abundance, and functional pathways. RESULTS: Independent microbial signatures were detected for PD (P = 4E-5), participants' region of residence within the United States (P = 3E-3), age (P = 0.03), sex (P = 1E-3), and dietary fruits/vegetables (P = 0.01). Among patients, independent signals were detected for catechol-O-methyltransferase-inhibitors (P = 4E-4), anticholinergics (P = 5E-3), and possibly carbidopa/levodopa (P = 0.05). We found significantly altered abundances of the Bifidobacteriaceae, Christensenellaceae, [Tissierellaceae], Lachnospiraceae, Lactobacillaceae, Pasteurellaceae, and Verrucomicrobiaceae families. Functional predictions revealed changes in numerous pathways, including the metabolism of plant-derived compounds and xenobiotics degradation. CONCLUSION: PD is accompanied by dysbiosis of gut microbiome. Results coalesce divergent findings of prior studies, reveal altered abundance of several taxa, nominate functional pathways, and demonstrate independent effects of PD medications on the microbiome. The findings provide new leads and testable hypotheses on the pathophysiology and treatment of PD. © 2017 International Parkinson and Movement Disorder Society.


Subject(s)
Antiparkinson Agents/therapeutic use , Catechol O-Methyltransferase Inhibitors/therapeutic use , Cholinergic Antagonists/therapeutic use , Dysbiosis/epidemiology , Gastrointestinal Microbiome/genetics , Parkinson Disease/epidemiology , Age Factors , Bifidobacterium/genetics , Carbidopa/therapeutic use , Case-Control Studies , Confounding Factors, Epidemiologic , Diet , Drug Combinations , Dysbiosis/microbiology , Female , Fruit , Humans , Lactobacillaceae/genetics , Levodopa/therapeutic use , Male , Parkinson Disease/drug therapy , Parkinson Disease/microbiology , Pasteurellaceae/genetics , RNA, Ribosomal, 16S/genetics , Risk Factors , Sex Factors , United States/epidemiology , Vegetables , Verrucomicrobia/genetics
18.
Am J Clin Nutr ; 104(2): 247-58, 2016 08.
Article in English | MEDLINE | ID: mdl-27413128

ABSTRACT

In observational studies, treatment assignment is a nonrandom process and treatment groups may not be comparable in their baseline characteristics, a phenomenon known as confounding. Propensity score (PS) methods can be used to achieve comparability of treated and nontreated groups in terms of their observed covariates and, as such, control for confounding in estimating treatment effects. In this article, we provide a step-by-step guidance on how to use PS methods. For illustrative purposes, we used simulated data based on an observational study of the relation between oral nutritional supplementation and hospital length of stay. We focused on the key aspects of PS analysis, including covariate selection, PS estimation, covariate balance assessment, treatment effect estimation, and reporting. PS matching, stratification, covariate adjustment, and weighting are discussed. R codes and example data are provided to show the different steps in a PS analysis.


Subject(s)
Biomedical Research/methods , Nutritional Sciences/methods , Propensity Score , Research Design/statistics & numerical data , Benchmarking , Dietary Supplements , Humans , Length of Stay , Observational Studies as Topic , Research Design/standards
19.
Nutr Res ; 36(1): 65-71, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26773782

ABSTRACT

The utility of fish oil supplements (FOS) in patients who survive an acute myocardial infarction (MI) remains controversial, with randomized trials showing less benefit than observational studies would suggest. The differences in the characteristics of MI patients who use FOS in routine clinical care are unknown but may help explain this discrepancy. We used data from a 24-site registry study in which extensive information was available on 4340 MI patients at admission and 1, 6, and 12 months postdischarge. After excluding those using FOS at admission (n = 651), those who died before the 1-month follow-up visit (n = 63), and those with missing data at 1 month (n = 1228), 2398 remained. Of them, 377 (16%) started FOS within 1 month of their MI. We analyzed 53 patient characteristics associated with FOS use. We observed differences (P < .001) in 20 demographic, socioeconomic, treatment, disease severity, and health status domains. The FOS users were more likely than nonusers to be white, married, financially secure, highly educated, and eating fish. They also had a higher ejection fraction at discharge, were more likely to have had in-hospital percutaneous coronary interventions, and were more likely to have participated in cardiac rehabilitation programs. The FOS users were less likely to have a history of diabetes, alcohol abuse, stroke, MI, and angina. In conclusion, post-MI patients who initiate FOS within 1 month of discharge in routine clinical practice differ substantially from those who do not. These differences are strongly associated with a better post-MI prognosis and may illuminate several sources of unmeasured confounding in observational studies.


Subject(s)
Dietary Supplements , Fish Oils/therapeutic use , Myocardial Infarction/prevention & control , Self Care , Aged , Cohort Studies , Confounding Factors, Epidemiologic , Female , Follow-Up Studies , Heart/physiopathology , Humans , Male , Middle Aged , Myocardial Infarction/epidemiology , Myocardial Infarction/physiopathology , Myocardial Infarction/rehabilitation , Percutaneous Coronary Intervention , Prognosis , Prospective Studies , Recurrence , Registries , Risk Factors , Severity of Illness Index , Socioeconomic Factors , Stroke Volume , United States/epidemiology
20.
Nutrients ; 8(1)2016 Jan 04.
Article in English | MEDLINE | ID: mdl-26742059

ABSTRACT

Selenium (Se) is a trace element which plays an important role in adipocyte hypertrophy and adipogenesis. Some studies suggest that variations in serum Se may be associated with obesity. However, there are few studies examining the relationship between dietary Se and obesity, and findings are inconsistent. We aimed to investigate the association between dietary Se intake and a panel of obesity measurements with systematic control of major confounding factors. A total of 3214 subjects participated in the study. Dietary Se intake was determined from the Willett food frequency questionnaire. Body composition was measured using dual-energy X-ray absorptiometry. Obese men and women had the lowest dietary Se intake, being 24% to 31% lower than corresponding normal weight men and women, classified by both BMI and body fat percentage. Moreover, subjects with the highest dietary Se intake had the lowest BMI, waist circumference, and trunk, android, gynoid and total body fat percentages, with a clear dose-dependent inverse relationship observed in both gender groups. Furthermore, significant negative associations discovered between dietary Se intake and obesity measurements were independent of age, total dietary calorie intake, physical activity, smoking, alcohol, medication, and menopausal status. Dietary Se intake alone may account for 9%-27% of the observed variations in body fat percentage. The findings from this study strongly suggest that high dietary Se intake is associated with a beneficial body composition profile.


Subject(s)
Adipose Tissue/drug effects , Obesity/etiology , Selenium/administration & dosage , Trace Elements/administration & dosage , Adult , Anthropometry , Body Composition , Body Mass Index , Diet Surveys , Female , Humans , Male , Middle Aged , Motor Activity , Newfoundland and Labrador , Obesity/blood , Obesity/physiopathology , Waist Circumference , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL